An Investigation Into the Feasibility of Beetroot Juice Supplementation in People Living With Alz… (NCT07258004) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
An Investigation Into the Feasibility of Beetroot Juice Supplementation in People Living With Alzheimer's Disease.
United Kingdom30 participantsStarted 2026-03
Plain-language summary
The goal of this clinical trial is to learn if taking a beetroot juice supplement will work in people living with Alzheimer's disease. The main questions it aims to answer are:
* Can people living with Alzheimer's disease realistically drink beetroot juice regularly (for example, is it easy to take, free from side effects and acceptable)?
* Does drinking beetroot juice twice a day improve health in people living with Alzheimer's disease?
Researchers will look at how you managed with the beetroot juice, as well as if there were any improvements in your health measures.
Participants will:
* Complete testing before and after the intervention for no more than 3 hours each time
* Complete a 1-day food diary before testing
* Take a beetroot juice supplementation twice daily for 1-week
* Keep a note of any problems with the beetroot juice
Who can participate
Age range
65 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged 65-85 years
* Mild or Moderate Alzheimer's disease
* Participants must be able to speak, read, and understand English to participate in this study.
* To support adherence, participants are asked to have a carer, partner, friend, or family member available to assist with reminders to take the shots twice daily.
Exclusion Criteria:
* Advanced or severe Alzheimer's Disease
* Diagnosis of an additional neurological condition
* Have used antibiotics in the last month
* Use of mouthwash in the last month
* Use of medication affecting nitrate metabolism (for example proton pump inhibitors, Isosorbide Mononitrate, Sildenafil or Glyceryl Trinitrate).
* Unable to provide informed consent
* Allergies to beetroot
* Taking part in pharmacological trials
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Feasibility of a beetroot juice intervention in people living with Alzheimer's disease
Timeframe: From enrolment to the post-intervention testing 8-days later.